Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Rachel Scott, MD,MPH,FACOG
Scientific Director
MedStar Health Research Institute
Poster(s):
(P-500) Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-1401) Association Between Intimate Partner Violence and Antiretroviral Adherence Among Pregnant Women Living with HIV
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1405) Drivers of Unplanned Pregnancy among Women with HIV in the Northern and Southern United States.
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1415) Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT